Chemically modified liposomes carrying TRAIL target activated hepatic stellate cells and ameliorate hepatic fibrosis in vitro and in vivo-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Chemically modified liposomes carrying TRAIL target activated hepatic stellate cells and ameliorate hepatic fibrosis in vitro and in vivo

Published:2018-12-27 Issue:3 Volume:23 Page:1951-1962
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J Cell Mol Med

Author:

Li Qinghua¹^ORCID,Ding Youcheng²,Guo Xinlai²,Luo Shenggen³,Zhuang Huiren²,Zhou JingE³,Xu Nan³,Yan Zhiqiang³

Affiliation:

1. Department of Gastroenterology; Shanghai East Hospital, Tongji University; Shanghai China

2. Department of Hepatology and Pancreatology; Shanghai East Hospital, Tongji University; Shanghai China

3. Institute of Biomedical Engineering and Technology; School of Chemistry and Molecular Engineering, East China Normal University; Shanghai China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jcmm.14097/fullpdf

Reference40 articles.

1. Hepatic stellate cells as key target in liver fibrosis;Higashi;Adv Drug Deliv Rev,2017

2. Activated stellate cells express the TRAIL receptor-2/death receptor-5 and undergo TRAIL-mediated apoptosis;Taimr;Hepatology,2003

3. Macrophage heterogeneity in liver injury and fibrosis;Tacke;J Hepatol,2014

4. NK cells from HCV-infected patients effectively induce apoptosis of activated primary human hepatic stellate cells in a TRAIL-, FasL- and NKG2D-dependent manner;Glässner;Lab Invest,2012

5. TRAIL signaling and synergy mechanisms used in TRAIL-based combination therapies;Hellwig;Mol Cancer Ther,2012

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in Noninvasive Molecular Imaging Probes for Liver Fibrosis Diagnosis;Biomaterials Research;2024-01

2. Liver Cell Type-Specific Targeting by Nanoformulations for Therapeutic Applications;International Journal of Molecular Sciences;2023-07-24

3. Understanding the Potential Role of Nanotechnology in Liver Fibrosis: A Paradigm in Therapeutics;Molecules;2023-03-20

4. Recent Advances in the Development of Nanodelivery Systems Targeting the TRAIL Death Receptor Pathway;Pharmaceutics;2023-02-03

5. Nano-TRAIL: a promising path to cancer therapy;Cancer Drug Resistance;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3